Naimish Patel
About
Naimish Patel is a scholar working on Physiology, Epidemiology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Naimish Patel has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 13 papers in Epidemiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Naimish Patel's work include Asthma and respiratory diseases (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers) and Allergic Rhinitis and Sensitization (9 papers). Naimish Patel is often cited by papers focused on Asthma and respiratory diseases (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers) and Allergic Rhinitis and Sensitization (9 papers). Naimish Patel collaborates with scholars based in United States, France and Sweden. Naimish Patel's co-authors include Henry Koziel, Souvenir D. Tachado, Jinping Zhu, Neil M.H. Graham, Michael Boyle, David M. Rodman, Ernst Rietschel, Steven M. Rowe, David Waltz and Susanna A. McColley and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Medicine.
In The Last Decade
Naimish Patel
52 papers receiving 2.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Naimish Patel United States | 24 | 650 | 550 | 459 | 438 | 435 | 55 | 2.2k | ||
| U. Schauer Germany | 24 | 514 0.8× | 1.1k 2.0× | 819 1.8× | 1.4k 3.1× | 417 1.0× | 61 | 3.0k | ||
| Harumi Suzaki Japan | 24 | 443 0.7× | 666 1.2× | 583 1.3× | 309 0.7× | 156 0.4× | 126 | 1.9k | ||
| Işıl Barlan Türkiye | 26 | 679 1.0× | 1.3k 2.3× | 1.0k 2.3× | 1.3k 3.0× | 573 1.3× | 85 | 2.9k | ||
| Maho Suzukawa Japan | 25 | 369 0.6× | 940 1.7× | 405 0.9× | 1.1k 2.5× | 94 0.2× | 83 | 2.3k | ||
| Cecilia Simonelli Italy | 24 | 152 0.2× | 711 1.3× | 540 1.2× | 1.4k 3.3× | 365 0.8× | 78 | 3.2k | ||
| Samuele E. Burastero Italy | 29 | 182 0.3× | 841 1.5× | 957 2.1× | 1.5k 3.5× | 473 1.1× | 89 | 3.2k | ||
| Arnold I. Levinson United States | 27 | 386 0.6× | 240 0.4× | 235 0.5× | 1.2k 2.8× | 159 0.4× | 89 | 2.4k | ||
| Seth Thomas Scanlon United States | 19 | 419 0.6× | 722 1.3× | 394 0.9× | 2.1k 4.7× | 361 0.8× | 90 | 3.2k | ||
| S. Raimer United States | 22 | 227 0.3× | 162 0.3× | 316 0.7× | 213 0.5× | 811 1.9× | 132 | 2.3k | ||
| Motoyasu Iikura Japan | 25 | 318 0.5× | 1.2k 2.2× | 610 1.3× | 2.1k 4.7× | 152 0.3× | 84 | 3.0k |
Countries citing papers authored by Naimish Patel
Since
Specialization
Citations
This map shows the geographic impact of Naimish Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naimish Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naimish Patel more than expected).
Fields of papers citing papers by Naimish Patel
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Naimish Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naimish Patel. The network helps show where Naimish Patel may publish in the future.
Co-authorship network of co-authors of Naimish Patel
This figure shows the co-authorship network connecting the top 25 collaborators of Naimish Patel. A scholar is included among the top collaborators of Naimish Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naimish Patel. Naimish Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Deiteren, Annemie, et al.. (2025). A proof-of-mechanism trial in asthma with lunsekimig, a bispecific NANOBODY molecule. European Respiratory Journal. 65(4). 2401461–2401461.
2.
Maurer, Marcus, Thomas B. Casale, Sarbjit S. Saini, et al.. (2024). Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials. Journal of Allergy and Clinical Immunology. 154(1). 184–194.
3.
Suratt, Benjamin T., Tillmann Krahnke, Peter Florian, et al.. (2024). Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study. Respiratory Research. 25(1). 107–107.
4.
Simpson, Eric L., Jonathan I. Silverberg, Margitta Worm, et al.. (2024). Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 90(6). 1190–1199.
5.
Deiteren, Annemie, et al.. (2024). Elevated fractional exhaled nitric oxide is prevalent in those with mild-to-moderate asthma with self-reported asthma control. PA1222–PA1222.
6.
Máspero, Jorge, Claus Bachert, Fernando J. Martínez, et al.. (2023). Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies. Journal of Asthma and Allergy. Volume 16. 333–342.
7.
Yosipovitch, Gil, Nicholas Mollanazar, Sonja Ständer, et al.. (2023). Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. Nature Medicine. 29(5). 1180–1190.
8.
Laidlaw, Tanya M., Claus Bachert, Nikhil Amin, et al.. (2021). Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Annals of Allergy Asthma & Immunology. 126(5). 584–592.e1.
9.
Bansal, Ashish, Eric L. Simpson, Amy S. Paller, et al.. (2021). Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma. American Journal of Clinical Dermatology. 22(1). 101–115.
10.
Tohda, Yuji, Yoichi Nakamura, Takao Fujisawa, et al.. (2020). Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study. Allergology International. 69(4). 578–587.
11.
Beck, Lisa A., Diamant Thaçi, Mette Deleuran, et al.. (2020). Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis. American Journal of Clinical Dermatology. 21(4). 567–577.
12.
Desrosiers, Martin, Claus Bachert, Peter W. Hellings, et al.. (2019). Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS- 24, SINUS- 52 phase 3 studies. Allergy. 74. 330–331.
13.
Laidlaw, Tanya M., Joaquim Mullol, Giorgio Walter Canonica, et al.. (2019). Dupilumab (DPL) Improves Upper and Lower Airway Outcomes in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) with Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease (NSAID-ERD): Pooled Results From SINUS-24, SINUS-52 Phase 3 Trials. PA539–PA539.
14.
Abdulai, Raolat M., Naimish Patel, Michael I. Polkey, et al.. (2017). Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 197(4). 433–449.
15.
Patel, Naimish, Medhavi Bole, Cheng Chen, et al.. (2012). Cell Elasticity Determines Macrophage Function. PLoS ONE. 7(9). e41024–e41024.
16.
Anandaiah, Asha, Keertan Dheda, Joseph Keane, et al.. (2010). Novel Developments in the Epidemic of Human Immunodeficiency Virus and Tuberculosis Coinfection. American Journal of Respiratory and Critical Care Medicine. 183(8). 987–997.
17.
Patel, Naimish, Jinping Zhu, Souvenir D. Tachado, et al.. (2007). HIV Impairs TNF-α Mediated Macrophage Apoptotic Response to Mycobacterium tuberculosis. The Journal of Immunology. 179(10). 6973–6980.
18.
Patel, Naimish, et al.. (2005). The Influence of Diagnostic Bronchoscopy on Clinical Outcomes Comparing Adult Autologous and Allogeneic Bone Marrow Transplant Patients. CHEST Journal. 127(4). 1388–1396.
19.
Patel, Naimish. (2005). The Influence of Diagnostic Bronchoscopy on Clinical Outcomes Comparing Adult Autologous and Allogeneic Bone Marrow Transplant Patients<xref rid="AFF1"><sup>*</sup></xref>. CHEST Journal. 127(4). 1388–1388.
20.
Patel, Naimish & Henry Koziel. (2004). Pneumocystis jiroveci Pneumonia in Adult Patients with AIDS. PubMed. 3(6). 381–397.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by U. Schauer Breakdown of academic impact, for papers by Harumi Suzaki Breakdown of academic impact, for papers by Işıl Barlan Breakdown of academic impact, for papers by Maho Suzukawa Breakdown of academic impact, for papers by Cecilia Simonelli Breakdown of academic impact, for papers by Samuele E. Burastero Breakdown of academic impact, for papers by Arnold I. Levinson Breakdown of academic impact, for papers by Seth Thomas Scanlon Breakdown of academic impact, for papers by S. Raimer Breakdown of academic impact, for papers by Motoyasu Iikura